{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:24:18Z","timestamp":1792301058793,"version":"4.4.0"},"reference-count":5,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T00:00:00Z","timestamp":1446422400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP in Immunology"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The protocol described in this appendix allows for light microscopic quantitation of cell viability. Cells are suspended in PBS containing trypan blue and then examined to determine the percentage of cells that have clear cytoplasm (viable cells) versus cells that have blue cytoplasm (nonviable cells). \u00a9 2015 by John Wiley &amp; Sons, Inc.<\/jats:p>","DOI":"10.1002\/0471142735.ima03bs111","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T08:05:53Z","timestamp":1446451553000},"source":"Crossref","is-referenced-by-count":1100,"title":["Trypan Blue Exclusion Test of Cell Viability"],"prefix":"10.1002","volume":"111","author":[{"given":"Warren","family":"Strober","sequence":"first","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, NIH  Bethesda Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,2]]},"reference":[{"key":"e_1_2_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1590\/1414\u2010431X20143437"},{"key":"e_1_2_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im0504s49"},{"key":"e_1_2_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.20438"},{"key":"e_1_2_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.ima03as21"},{"key":"e_1_2_3_2_2_1","unstructured":"Avelar\u2010Freitaset al. 2014.See above."}],"container-title":["Current Protocols in Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2F0471142735.ima03bs111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/0471142735.ima03bs111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/0471142735.ima03bs111","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/0471142735.ima03bs111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T04:46:50Z","timestamp":1692506810000},"score":1,"resource":{"primary":{"URL":"https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/10.1002\/0471142735.ima03bs111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1002\/0471142735.ima03bs111"],"URL":"https:\/\/doi.org\/10.1002\/0471142735.ima03bs111","archive":["Portico"],"relation":{},"ISSN":["1934-3671","1934-368X"],"issn-type":[{"value":"1934-3671","type":"print"},{"value":"1934-368X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}